CompletedPhase 1

A Study of MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002)

NCT05466422

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

California Clinical Trials Medical Group managed by PAREXEL-PAREXEL International ( Site 0007)

Glendale, California, United States

+11 additional locations

Save this trial

California Clinical Trials Medical Group managed by PAREXEL-PAREXEL International ( Site 0007)Glendale, California, United States
Collaborative Neuroscience Research, LLC ( Site 0009)Los Alamitos, California, United States
NRC Research Institute ( Site 0015)Orange, California, United States
Velocity Clinical Research, Hallandale Beach ( Site 0001)Hallandale, Florida, United States
Research Centers of America ( Hollywood ) ( Site 0004)Hollywood, Florida, United States
K2 Medical Research ( Site 0005)Maitland, Florida, United States
Charter Research - Winter Park ( Site 0012)Orlando, Florida, United States
Progressive Medical Research-Alzheimer's Team ( Site 0013)Port Orange, Florida, United States
Charter Research - Lady Lake ( Site 0011)The Villages, Florida, United States
CenExel iResearch, LLC ( Site 0002)Decatur, Georgia, United States
Global Medical Institutes LLC; Princeton Medical Institute ( Site 0003)Princeton, New Jersey, United States
Neuro-Behavioral Clinical Research ( Site 0016)North Canton, Ohio, United States